Apop Biosciences
Apop Biosciences develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
In the News
US Patent Granted to Apop Biosciences
Melbourne-based life science company Apop Biosciences has announced it has been granted a US Patent relating to its platform technology and lead product CalRexinTM.
Funding round open
Apop Biosciences has an open investment round to raise funding from private investors. Investors have the opportunity to become part of a company with rapidly growing potential. Contact us for an investment proposal.